id: distance_to_mat_prescriber_to_mat_continuity_of_care
name: Distance to Medication-Assisted Treatment Prescriber â†’ Continuity of Pharmacotherapy
  for Opioid Use Disorder
from_node:
  node_id: distance_to_mat_prescriber
  node_name: Distance to Medication-Assisted Treatment Prescriber
to_node:
  node_id: mat_continuity_of_care
  node_name: Continuity of Pharmacotherapy for Opioid Use Disorder
direction: negative
category: healthcare_access
mechanism_pathway:
- 'Step 1: Greater travel distances to MAT prescribers create logistical barriers
  including increased time, cost, and transportation challenges for rural Medicaid
  enrollees'
- 'Step 2: These barriers reduce ability to maintain regular appointments for prescription
  refills and clinical monitoring'
- 'Step 3: Disruptions in appointment attendance lead to gaps in medication availability'
- 'Step 4: Discontinuous pharmacotherapy reduces treatment effectiveness and increases
  relapse risk'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: Evan S Cole et al. 2019. "The Role of Primary Care in Improving
    Access to Medication-Assisted Treatment for Rural Medicaid Enrollees with Opioid
    Use Disorder.." *Journal of general internal medicine*. https://doi.org/10.1007/s11606-019-04943-6
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:07.501186'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
moderators:
- name: travel_distance_threshold
  direction: weakens
  strength: strong
  description: Traveling mean distance greater than 45 miles significantly reduces
    odds of maintaining continuity of pharmacotherapy
_source_file: /Users/mauriceelhelou/Library/CloudStorage/OneDrive-HarvardUniversity/New
  folder (2)/healthsystems/mechanism-bank/mechanisms/healthcare_access/distance_to_mat_prescriber_to_mat_continuity_of_care.yaml
_category: healthcare_access
